{
     "PMID": "24123016",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20131209",
     "LR": "20131014",
     "IS": "1791-7530 (Electronic) 0250-7005 (Linking)",
     "VI": "33",
     "IP": "10",
     "DP": "2013 Oct",
     "TI": "Activity of LaSOM 65, a monastrol-derived compound, against glioblastoma multiforme cell lines.",
     "PG": "4463-8",
     "AB": "BACKGROUND/AIM: Despite recent progress in glioblastoma treatment, prognosis is still poor. Monastrol is a kinesin spindle protein (KSP) inhibitor and anticancer effects for this molecule have been reported. Here we describe the effect of LaSOM 65, a monastrol derivated compound, against glioma cell lines. MATERIALS AND METHODS: Cell counting, viability assay, lactate dehydrogenase (LDH) activity, cell-cycle analysis, immunofluorescence and organotypic hippocampal slice cultures were performed. RESULTS: LaSOM 65 reduced cell number and cell viability of gliomas cells, but did not cause arrest in the cell cycle at the G2/M phase. Measurement of LDH activity showed that LaSOM 65 induces necrosis after 48 h of treatment. CONCLUSION: LaSOM 65 appears to a be promising new molecule to treat glioblastoma since it promotes a decrease of cell growth and cell viability of glioma cells in vitro and does not induces the neurotoxic characteristics of the anti-mitotic drugs currently used.",
     "FAU": [
          "Stuepp, Cristiane Santos",
          "Figueiro, Fabricio",
          "Mendes, Franciane Brackmann",
          "Braganhol, Elizandra",
          "Bernardi, Andressa",
          "Frozza, Rudimar Luiz",
          "Salbego, Christianne Gazzana",
          "Canto, Romulo Faria Santos",
          "Russowsky, Dennis",
          "Eifler-Lima, Vera Lucia",
          "Battastini, Ana Maria Oliveira"
     ],
     "AU": [
          "Stuepp CS",
          "Figueiro F",
          "Mendes FB",
          "Braganhol E",
          "Bernardi A",
          "Frozza RL",
          "Salbego CG",
          "Canto RF",
          "Russowsky D",
          "Eifler-Lima VL",
          "Battastini AM"
     ],
     "AD": "Ramiro Barcelos Street, 2600 Lab 22. Zip code: 90035-003, Porto Alegre/RS, Brazil. abattastini@gmail.com.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Greece",
     "TA": "Anticancer Res",
     "JT": "Anticancer research",
     "JID": "8102988",
     "RN": [
          "0",
          "(5-ethoxycarbonyl-6-methyl-4-(3-nitrophenyl)-3,4-dihydropyrimidin-2-(1H)-thione)",
          "0 (Antineoplastic Agents)",
          "0 (Pyrimidines)",
          "0 (Thiones)",
          "0 (Tubulin)",
          "EC 1.1.1.27 (L-Lactate Dehydrogenase)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antineoplastic Agents/*pharmacology",
          "Cell Cycle Checkpoints/drug effects",
          "Cell Line, Tumor",
          "Cell Nucleus/drug effects",
          "Cell Survival/drug effects",
          "Drug Screening Assays, Antitumor",
          "Glioblastoma",
          "Hippocampus/drug effects",
          "Humans",
          "L-Lactate Dehydrogenase/metabolism",
          "Necrosis",
          "Pyrimidines/*pharmacology",
          "Rats",
          "Thiones/*pharmacology",
          "Tissue Culture Techniques",
          "Tubulin/metabolism"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Glioma",
          "KSP inhibitors",
          "LaSOM 65",
          "antitumor activity"
     ],
     "EDAT": "2013/10/15 06:00",
     "MHDA": "2013/12/16 06:00",
     "CRDT": [
          "2013/10/15 06:00"
     ],
     "PHST": [
          "2013/10/15 06:00 [entrez]",
          "2013/10/15 06:00 [pubmed]",
          "2013/12/16 06:00 [medline]"
     ],
     "AID": [
          "33/10/4463 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Anticancer Res. 2013 Oct;33(10):4463-8.",
     "term": "hippocampus"
}